96 related articles for article (PubMed ID: 24831766)
1. Relationship between coronary in-stent restenosis and plasma urotensin II level.
Yavuz F; Ozer O; Ercan S; Yuce M; Davutoglu V; Alici H; Pusuroglu H; Orkmez M; Kaplan M; Basanalan F; Tarakcioglu M
Minerva Cardioangiol; 2014 Jun; 62(3):297-303. PubMed ID: 24831766
[TBL] [Abstract][Full Text] [Related]
2. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
[TBL] [Abstract][Full Text] [Related]
3. Peripheral CD34+ cells and the risk of in-stent restenosis in patients with coronary heart disease.
Schober A; Hoffmann R; Oprée N; Knarren S; Iofina E; Hutschenreuter G; Hanrath P; Weber C
Am J Cardiol; 2005 Oct; 96(8):1116-22. PubMed ID: 16214449
[TBL] [Abstract][Full Text] [Related]
4. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
Hitsumoto T; Takahashi M; Iizuka T; Shirai K
J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
[TBL] [Abstract][Full Text] [Related]
5. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
6. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
[TBL] [Abstract][Full Text] [Related]
7. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
[TBL] [Abstract][Full Text] [Related]
8. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
[TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.
Cassese S; Byrne RA; Tada T; Pinieck S; Joner M; Ibrahim T; King LA; Fusaro M; Laugwitz KL; Kastrati A
Heart; 2014 Jan; 100(2):153-9. PubMed ID: 24270744
[TBL] [Abstract][Full Text] [Related]
10. The effect of stent coating on stent deliverability: direct randomised comparison of drug eluting and bare metal stents using the same stent platform.
Siminiak T; Link R; Wołoszyn M; Kałmucki P; Baszko A
Kardiol Pol; 2012; 70(10):998-1002. PubMed ID: 23080088
[TBL] [Abstract][Full Text] [Related]
11. The association of red cell distribution width with in-stent restenosis in patients with stable coronary artery disease.
Kurtul A; Murat SN; Yarlioglues M; Duran M; Karadeniz M; Ergun G; Akyel A; Mendi MA; Oksuz F
Platelets; 2015; 26(1):48-52. PubMed ID: 24831828
[TBL] [Abstract][Full Text] [Related]
12. [Association between plasma adiponectin level and in-stent restenosis after coronary stenting].
Qin Q; Lu YR; Li Y; Kou L; Feng JP; Chen G; Li CJ; Zhao BR
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Mar; 38(3):239-42. PubMed ID: 20450566
[TBL] [Abstract][Full Text] [Related]
13. [Role of eosinophil granulocytes in the occurrence of restenosis in patients after coronary stenting with drug-eluting stents].
Gabbasov ZA; Kozlov SG; Imaeva AÉ; Saburova OS; Masenko VP
Ter Arkh; 2014; 86(9):90-6. PubMed ID: 25518512
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical follow-up after drug-eluting stent implantation for bare metal in-stent restenosis.
Berta B; Ruzsa Z; Barczi G; Becker D; Geller L; Jambrik Z; Molnar L; Szabo G; Merkely B
J Interv Cardiol; 2013 Jun; 26(3):271-7. PubMed ID: 23586796
[TBL] [Abstract][Full Text] [Related]
15. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
[TBL] [Abstract][Full Text] [Related]
17. Plasma osteopontin concentration is elevated in patients with coronary bare metal stent restenosis.
Yilmaz KC; Bal UA; Karacaglar E; Okyay K; Aydinalp A; Yildirir A; Muderrisoglu H
Acta Cardiol; 2018 Feb; 73(1):69-74. PubMed ID: 28841817
[TBL] [Abstract][Full Text] [Related]
18. Sirolimus versus bare metal stent implantation in patients with total coronary occlusions: subgroup analysis of the Stenting Coronary Arteries in Non-Stress/Benestent Disease (SCANDSTENT) trial.
Kelbaek H; Helqvist S; Thuesen L; Kløvgaard L; Jørgensen E; Saunamäki K; Krusell LR; Bøtker HE; Engstrøm T; Jensen GV;
Am Heart J; 2006 Nov; 152(5):882-6. PubMed ID: 17070149
[TBL] [Abstract][Full Text] [Related]
19. Late-phase inflammatory response as a feature of in-stent restenosis after drug-eluting stent implantation.
Yoneda S; Abe S; Kanaya T; Oda K; Nishino S; Kageyama M; Taguchi I; Masawa N; Inoue T
Coron Artery Dis; 2013 Aug; 24(5):368-73. PubMed ID: 23744617
[TBL] [Abstract][Full Text] [Related]
20. [Clinical and angiographic outcome in coronary artery disease patients with type-II diabetes mellitus undergoing elective bare-metal stenting or drug-eluting stenting].
Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Ma WH; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Chen JL; Gao RL
Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):523-6. PubMed ID: 17711711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
